PR Newswire Financial
prCenter
Superluminal Medicines Announces Oversubscribed $60 Million Series B Financing to Advance Lead Program in Rare Genetic Forms of Obesity into the Clinictranslating…
Financing led by BVF Partners, L.P. and includes participation from Deep Track Capital and Perceptive Advisors alongside existing investors RA Capital Management, Insight Partners, NVIDIA, Catalio Capital Management, Eli Lilly and Company, Cooley, and Gaingels Proceeds will…
Keywords#Financing#capital#Advance#Advance Lead#Advance Lead Program
Comments
Sign in to join the discussion.
Loading comments…